HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

AbstractBACKGROUND:
Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both diagnosis and treatment are required. Autoantibodies directed against apolipoprotein A-I (ApoA-I) represent promising biomarkers for use in risk stratification of CVD and may also play a direct role in pathogenesis.
METHODOLOGY:
To characterize the anti-ApoA-I autoantibody response, we measured the immunoreactivity to engineered peptides corresponding to the different alpha-helical regions of ApoA-I, using plasma from acute chest pain cohort patients known to be positive for anti-ApoA-I autoantibodies.
PRINCIPAL FINDINGS:
Our results indicate that the anti-ApoA-I autoantibody response is strongly biased towards the C-terminal alpha-helix of the protein, with an optimized mimetic peptide corresponding to this part of the protein recapitulating the diagnostic accuracy for an acute ischemic coronary etiology (non-ST segment elevation myocardial infarction and unstable angina) obtainable using intact endogenous ApoA-I in immunoassay. Furthermore, the optimized mimetic peptide strongly inhibits the pathology-associated capacity of anti-ApoA-I antibodies to elicit proinflammatory cytokine release from cultured human macrophages.
CONCLUSIONS:
In addition to providing a rationale for the development of new approaches for the diagnosis and therapy of CVD, our observations may contribute to the elucidation of how anti-ApoA-I autoantibodies are elicited in individuals without autoimmune disease.
AuthorsSabrina Pagano, Hubert Gaertner, Fabrice Cerini, Tiphaine Mannic, Nathalie Satta, Priscila Camillo Teixeira, Paul Cutler, François Mach, Nicolas Vuilleumier, Oliver Hartley
JournalPloS one (PLoS One) Vol. 10 Issue 7 Pg. e0132780 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26177543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • APOA1 protein, human
  • Apolipoprotein A-I
  • Autoantibodies
  • Immobilized Proteins
  • Immunoglobulin G
  • Inflammation Mediators
  • Interleukin-6
  • Peptides
  • Tumor Necrosis Factor-alpha
Topics
  • Amino Acid Sequence
  • Apolipoprotein A-I (chemistry, immunology)
  • Autoantibodies (immunology)
  • Cardiovascular Diseases (blood, diagnosis, therapy)
  • Circular Dichroism
  • Humans
  • Immobilized Proteins (metabolism)
  • Immunoglobulin G (metabolism)
  • Inflammation Mediators (metabolism)
  • Interleukin-6 (pharmacology)
  • Molecular Sequence Data
  • Peptides (chemistry)
  • Protein Engineering
  • Protein Structure, Secondary
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: